Gene Panel Companies

Disclaimer: List of key companies in no particular orderLatest Gene panel Companies Update

• 
  Oct 2023: With the addition of state-of-the-art transcriptome analysis, Centogene N.V., the vital life science collaborator for data-driven solutions in rare and neurological illnesses, announced the extension of MOx, the company's multiomic diagnostic portfolio. CENTOGENE's MOx 2.0 is a single-step multiomic solution that integrates DNA sequencing, biochemical testing, and RNA sequencing to give doctors the most comprehensive testing capacity. Through transcriptomics, one can uncover RNA patterns specific to mutations, gene expression variations, and tissues and cells' responses to physiological or environmental changes. A more complete understanding of disease biology and treatment response can be created using RNA sequencing. A more comprehensive understanding of the biology of the disease can be created by including RNA sequencing, which accounts for approximately 60% of tested individuals with suspected genetic diseases.

• 
  July 2023: A biotechnology business focused on advanced gene synthesis, Eurofins Genomics Blue Heron, announced the opening of its in-vitro transcription (IVT) messenger RNA (mRNA) synthesis service. A press release from the company states that the new synthesis service is intended to provide a comprehensive answer for researchers looking for quick turnaround times on high-quality, customizable mRNA synthesis. As per the press statement, the novel synthesis service can manage diverse applications and offers adaptable mRNA synthesis functionalities to cater to research requirements. Among other domains, it is intended for use in molecular biology, finding drugs, vaccine development, and gene therapy.

• Eurofins Genomics


• Illumina Inc


• Gencove


• Centogene NV


• Myriad Genetic Laboratories Inc.


• Agilent Technologies


• Thermo Fisher Scientific


• Foundation Medicine Inc.


• Bio-Rad Laboratories Inc.


• Guardant Health Inc.